BioMimetic To Present at 30th Annual J.P. Morgan Healthcare Conference
Jan. 10, 2012
|
|
|
BioMimetic Therapeutics, Inc. to Present at the J.P Morgan Healthcare Conference
Jan. 5, 2012
|
|
|
BioMimetic Receives PMA Post Panel Response Letter
Jan. 3, 2012
|
|
|
BioMimetic Therapeutics Announces Approval to Market GEM 21S® in the European Union
Jan. 3, 2012
|
|
|
BioMimetic Therapeutics, Inc. Reports 2011 Third Quarter Earnings Results
Nov. 8, 2011
|
|
|
BioMimetic Therapeutics, Inc. Receives Approval to Commercialize Augment® Bone Graft in Australia
Oct. 19, 2011
|
|
|
BioMimetic Therapeutics, Inc. Reports Second Quarter 2011 Earnings Results
Aug. 4, 2011
|
|
|
BioMimetic Therapeutics Announces Highlights from 2011 Annual Meeting of Stockholders
June 14, 2011
|
|
|
BioMimetic Therapeutics Completes Enrollment in Augment™ Rotator Cuff Graft Pilot Trial
June 7, 2011
|
|
|
BioMimetic Therapeutics' Augment™ Bone Graft Receives Positive Recommendation from FDA Advisory Committee
May 12, 2011
|
|
|
BioMimetic Therapeutics, Inc. Reports First Quarter 2011 Earnings Results
May 9, 2011
|
|
|
BioMimetic Therapeutics Augment™ Bone Graft Advisory Panel Meeting Date Published in Federal Register; Meeting to be Held May 12 in Gaithersburg, MD
March 29, 2011
|
|
|
BioMimetic Therapeutics, Inc. Reports 2010 Fourth Quarter and Year End Earnings Results
March 10, 2011
|
|
|
BioMimetic Therapeutics, Inc. Highlights Commercial and Product Development Activities during AAOS
Feb. 17, 2011
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Commercial and Product Development Activities during AAOS
Feb. 10, 2011
|
|
|
BioMimetic Therapeutics Announces Date of FDA Advisory Panel Review of Augment™ Bone Graft; Panel Tentatively Scheduled for May 12, 2011
Jan. 31, 2011
|
|
|
BioMimetic Therapeutics Presents Pre-Clinical Sports Medicine Data at the 2011 ORS Meeting
Jan. 6, 2011
|
|
|
BioMimetic Therapeutics, Inc. Continues to Enhance Patent Portfolio; Canadian protection for orthopedic product candidates until 2025
Dec. 16, 2010
|
|
|
BioMimetic Therapeutics, Inc. Initiates Augment™ Rotator Cuff Graft Trial; Trial Aimed at Large Sports Medicine Market
Dec. 7, 2010
|
|
|
BioMimetic Therapeutics Reports 2010 Third Quarter Earnings Results
Nov. 3, 2010
|
|
|
BioMimetic Therapeutics PMA Remains on Track
Sep. 8, 2010
|
|
|
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteochondritis Dissecans
Aug. 12, 2010
|
|
|
BioMimetic Therapeutics Reports 2010 Second Quarter Earnings Results
Aug. 5, 2010
|
|
|
BioMimetic Therapeutics Announces Closing of Public Offering and Exercise of Over-Allotment Option
July 20, 2010
|
|
|
BioMimetic Therapeutics, Inc. Prices Public Offering of Common Stock
July 14, 2010
|
|
|
BioMimetic Therapeutics, Inc. Announces Commencement of Public Offering of Common Stock
July 12, 2010
|
|
|
BioMimetic Therapeutics, Inc. Releases Clinical Update Including Positive 52-Week Data from North American Pivotal Trial
July 7, 2010
|
|
|
BioMimetic Therapeutics Receives Filing Letter from FDA for Augment™ Bone Graft PMA
June 28, 2010
|
|
|
BioMimetic Therapeutics Reports 2010 First Quarter Earnings Results; Additional Analyses Further Strengthen Pivotal Trial Data Package
May 10, 2010
|
|
|
BioMimetic Therapeutics Reports 2009 Fourth Quarter and Year End Results; Company Releases Additional Pivotal Data on Augment
March 11, 2010
|
|
|
BioMimetic Therapeutics Presents Promising Pre-Clinical Sports Medicine Data at the 2010 ORS Meeting
March 9, 2010
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Pre-Clinical and Clinical Activities at ORS and AAOS Meetings; Company to Host Analyst and Investor Meeting on March 11
March 4, 2010
|
|
|
BioMimetic Therapeutics Completes Submission of PMA Application for FDA Approval of Augment™ Bone Graft
Feb. 17, 2010
|
|
|
BioMimetic Therapeutics, Inc. Patent Portfolio Further Strengthened
Feb. 1, 2010
|
|
|
